P0p (Trusted · 2026)

While p0p itself is used in animal models, the research it enables is critical for developing new human therapies. Traditional anti-clotting drugs often carry a high risk of internal bleeding. Interestingly, research using p0p has shown that blocking GPIbα can protect the brain from stroke damage without significantly increasing the risk of intracranial bleeding, making this receptor a "holy grail" target for future antithrombotic drugs. Summary of Research Applications

Studies have shown that treating mice with p0p/B Fab fragments significantly reduces the size of brain infarcts (damaged tissue) following a stroke. While p0p itself is used in animal models,

Researchers use p0p/B to simulate the effects of certain medications or genetic conditions. Its primary functions in laboratory settings include: Summary of Research Applications Studies have shown that

The p0p/B antibody is a powerful tool in hematology and vascular biology. It is designed to target and block the (Glycoprotein Ib alpha) receptor on the surface of platelets. Platelets are the blood components responsible for stopping bleeding, but their "over-activation" can lead to dangerous conditions like thrombosis (blood clots) and stroke. The Role of p0p in Medical Research It is designed to target and block the

Beyond simple clotting, p0p helps scientists understand "thrombo-inflammation"—a process where clotting and immune responses feed into each other, worsening tissue damage in diseases like atherosclerosis. Clinical Significance

By blocking the interaction between platelets and the von Willebrand factor (vWF), p0p prevents platelets from sticking to injured blood vessel walls, effectively stopping the formation of occlusive clots.